Skip to content

Percutaneous Microelectrolysis (MEP) Versus Ischemic Compression in Miofascial Trigger Points

Short Term Effects in Pressure-pain Threshold of Percutaneous Galvanic Microcurrent Versus Ischemic Compression in the Trapezius Trigger Points

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03708107
Enrollment
30
Registered
2018-10-17
Start date
2018-10-22
Completion date
2019-12-10
Last updated
2019-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Trigger Point Pain

Keywords

galvanic current, electrolysis, myofascial trigger point, percutaneous microelectrolysis, dry needling, ischemic compression

Brief summary

The Percutaneous Microelectrolysis ® (MEP®) is a technique that employs a galvanic current up to 990 uA, which is applied percutaneously with an acupuncture needle connected to the cathode. Although it is used in tendinopathies, trigger points and muscle injuries, among other conditions, its bases are mostly empirical and there is lack of evidence. Ischemic compression is a manual therapy that is usually applied in muscle pain. Myofascial Pain Syndrome (MPS) usually presents painful myofascial trigger points (MTrPs). One methodology used to quantify the pain in MPS is the algometry, which measures the pressure pain threshold (PPT). The aim of this study was to compare the effects of MEP® with ischemic compression on MTrPs with algometry.

Interventions

DEVICEMEP

MEP® will be applied with an acupuncture needle (0,30 x 25 mm). The needle will be introduced perpendicularly to the MTrP with 100 uA and then increased up to 600 uA. The current will be paused if the patient feels a burning sensation, pain or oppression, waiting up to the patient feels no discomfort. The procedure will be repeated as many times is necessary until the patient do not feel any discomfort for more than 1 minute.

Ischemic compression will be applied perpendicularly to the MTrP, increasing gradually the pression until the patient refers the maximum tolerable pain. This pressure will be applied for 1 minute.

Sponsors

Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The researcher who did the algometry was masked. The researcher who did the statistical analysis was masked.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers * Between 18 to 30 years old. * Who referred MTrP in the upper trapezious. * PPT equal or less than 3 KgF/cm2

Exclusion criteria

* Being pregnant. * Taking analgesic medication at least 24 hours before the intervention. * Being in physical therapy treatment. * Needle phobia.

Design outcomes

Primary

MeasureTime frameDescription
Preasure Pain Threshold (PPT)24 hoursAlgometry is used to measure the Preasure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It was applied in the Miofascial Trigger points.

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026